Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
Author:
Publisher
Frontiers Media SA
Subject
Immunology,Immunology and Allergy
Reference73 articles.
1. Global Tuberculosis Report 2019
2. Drug repurposing is a new opportunity for developing drugs against neuropsychiatric disorders;Lee;Schizophr Res Treat.,2016
3. Literature mining, ontologies and information visualization for drug repurposing;Andronis;Brief Bioinform,2011
4. Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis;Rani;J Biomol Struct Dyn.,2019
5. Host-directed therapies for tackling multi-drug resistant tuberculosis: learning from the pasteur-bechamp debates: table 1;Zumla;Clin Infect Dis,2015
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment;Journal of Advanced Research;2024-08
2. Dual roles of myeloid-derived suppressor cells in various diseases: a review;Archives of Pharmacal Research;2024-07
3. MDSC expansion during HIV infection: regulators, ART and immune reconstitution;Genes & Immunity;2024-04-11
4. PDE5 inhibitors against cancer via mediating immune cells in tumor microenvironment: AI‐based approach for future drug repurposing exploration;Interdisciplinary Medicine;2024-03-16
5. Host-Directed Immunotherapy for Tuberculosis;Translational Research in Biomedical Sciences: Recent Progress and Future Prospects;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3